We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 131.08%
This Fund
S&P 500
This Quarter Est. Return
+25.91%
1 Year Est. Return
+131.08%
3 Year Est. Return
+497.29%
5 Year Est. Return
+787.25%
10 Year Est. Return
AUM
$41.3B
AUM Growth
+$4.26B
Cap. Flow
-$462M
Cap. Flow %
-1.12%
Top 10 Hldgs %
91.6%
Holding
1,678
New
553
Increased
134
Reduced
156
Closed
796

Sector Composition

Rank Sector Weight
1 Communication Services 0.07%
2 Consumer Discretionary 0.06%
3 Technology 0.02%
4 Healthcare 0.02%
5 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARRY icon
926
Array Technologies
ARRY
$924M
-5,598
Closed -$108K
ARRY icon
927
PUT
Array Technologies
ARRY
$924M
-22,200
Closed -$429K
ATEC icon
928
Alphatec Holdings
ATEC
$1.59B
-10,646
Closed -$131K
ATOS icon
929
CALL
Atossa Therapeutics
ATOS
$23M
-3,433
Closed -$27.2K
ATOS icon
930
Atossa Therapeutics
ATOS
$23M
-33
Closed -$265
ATOS icon
931
PUT
Atossa Therapeutics
ATOS
$23M
-127
Closed -$1K
AUR icon
932
CALL
Aurora
AUR
$14.2B
-900
Closed -$1.09K
AUR icon
933
Aurora
AUR
$14.2B
-15,870
Closed -$19.2K
AUR icon
934
PUT
Aurora
AUR
$14.2B
-15,800
Closed -$19.1K
AVDL
935
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
-10,900
Closed -$78K
AVDL
936
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
-1,500
Closed -$10.7K
AVIR icon
937
CALL
Atea Pharmaceuticals
AVIR
$376M
-22,500
Closed -$108K
AVXL icon
938
CALL
Anavex Life Sciences
AVXL
$292M
-20,200
Closed -$187K
AXSM icon
939
CALL
Axsome Therapeutics
AXSM
$10.9B
-900
Closed -$69.4K
AXSM icon
940
Axsome Therapeutics
AXSM
$10.9B
-2,119
Closed -$163K
AXSM icon
941
PUT
Axsome Therapeutics
AXSM
$10.9B
-200
Closed -$15.4K
BA icon
942
Boeing
BA
$187B
-1,070
Closed -$222K
BCRX icon
943
CALL
BioCryst Pharmaceuticals
BCRX
$2.29B
-7,000
Closed -$80.4K
BCRX icon
944
PUT
BioCryst Pharmaceuticals
BCRX
$2.29B
-3,200
Closed -$36.7K
BCTX
945
PUT
Briacell Therapeutics
BCTX
$29.3M
-5
Closed -$3.06K
BDTX icon
946
Black Diamond Therapeutics
BDTX
$102M
-17,295
Closed -$31.1K
BDTX icon
947
PUT
Black Diamond Therapeutics
BDTX
$102M
-17,900
Closed -$32.2K
BGFV
948
DELISTED
Big 5 Sporting Goods
BGFV
-34,292
Closed -$310K
BHP icon
949
CALL
BHP
BHP
$222B
-7,200
Closed -$447K
BHP icon
950
PUT
BHP
BHP
$222B
-3,200
Closed -$199K

Similar funds

Belvedere Trading's Q1 2023 Portfolio in Review

As of Q1 2023, Belvedere Trading held 1,678 positions worth $41.3B, up 12% from $37B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Belvedere Trading's Q1 2023 filing shows 553 new, 134 increased, 156 reduced and 796 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 279,308 shares worth $114M. The largest sale was Tesla, an estimated $80.1M.

By sector, the portfolio is most concentrated in Communication Services at 0.07% of assets, up from 0.02% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Belvedere Trading's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 279,308 shares worth $114M.
  • Belvedere Trading added most to Meta Platforms (Facebook) in Q1 2023, an estimated $14.6M increase.
  • Belvedere Trading's biggest Q1 2023 reduction was Tesla, cutting an estimated $80.1M.
  • Belvedere Trading fully exited Amazon in Q1 2023, selling an estimated $30.3M.
  • Belvedere Trading's ten largest holdings make up 92% of its $41.3B portfolio in Q1 2023.
  • Belvedere Trading opened 553 new positions and closed 796 in Q1 2023.
  • Belvedere Trading's portfolio value rose 12% quarter-over-quarter to $41.3B.

Based on Belvedere Trading's 13F filing for Q1 2023, filed 15 May 2023.